ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every Emmessar Biotech & Nutrition financial results announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Emmessar Biotech & Nutrition Ltd's board approved unaudited Q2 FY27 results for the quarter ended 30 September 2026. Net profit after tax was Rs 14.03 lakhs for the quarter, with total income of Rs 62.50 lakhs.
Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q1 FY27.
Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q4 FY26.
Emmessar Biotech & Nutrition reported a total income of ₹2.41 Crore for FY26. Net profit stood at ₹0.44 Crore, reflecting stable annual performance for investors.